<DOC>
	<DOCNO>NCT02634034</DOCNO>
	<brief_summary>The purpose study compare pharmacokinetics safety control release ( CR ) version pitavastatin ( also refer NK-104 ) immediate release ( IR ) pitavastatin healthy adult volunteer .</brief_summary>
	<brief_title>A Comparison Study Evaluate Pharmacokinetics Safety NK-104-CR Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<criteria>Subject provide write informed consent studyspecific evaluation perform . Subject healthy adult male female volunteer age 18 45 year , inclusive . Subject clinically significant abnormality basis medical history , physical examination finding , vital sign measurement , judge Investigator . Subject able willing comply protocol study procedure . Subject woman pregnant breastfeeding . Subject clinically relevant abnormality screen checkin assessment . Subject receive investigational drug within 30 day first dose study drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>